RadNet Revenue 2012-2025 | RDNT
RadNet annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- RadNet revenue for the quarter ending December 31, 2025 was $0.548B, a 14.8% increase year-over-year.
- RadNet revenue for the twelve months ending December 31, 2025 was $2.040B, a 11.51% increase year-over-year.
- RadNet annual revenue for 2025 was $2.04B, a 11.51% increase from 2024.
- RadNet annual revenue for 2024 was $1.83B, a 13.18% increase from 2023.
- RadNet annual revenue for 2023 was $1.617B, a 13.05% increase from 2022.
|
RadNet Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $2,040 |
| 2024 | $1,830 |
| 2023 | $1,617 |
| 2022 | $1,430 |
| 2021 | $1,315 |
| 2020 | $1,072 |
| 2019 | $1,154 |
| 2018 | $975 |
| 2017 | $922 |
| 2016 | $885 |
| 2015 | $810 |
| 2014 | $718 |
| 2013 | $703 |
| 2012 | $647 |
| 2011 | $585 |
|
RadNet Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-12-31 | $548 |
| 2025-09-30 | $523 |
| 2025-06-30 | $498 |
| 2025-03-31 | $471 |
| 2024-12-31 | $477 |
| 2024-09-30 | $461 |
| 2024-06-30 | $460 |
| 2024-03-31 | $432 |
| 2023-12-31 | $420 |
| 2023-09-30 | $402 |
| 2023-06-30 | $404 |
| 2023-03-31 | $391 |
| 2022-12-31 | $384 |
| 2022-09-30 | $350 |
| 2022-06-30 | $354 |
| 2022-03-31 | $342 |
| 2021-12-31 | $333 |
| 2021-09-30 | $333 |
| 2021-06-30 | $334 |
| 2021-03-31 | $315 |
| 2020-12-31 | $308 |
| 2020-09-30 | $292 |
| 2020-06-30 | $191 |
| 2020-03-31 | $282 |
| 2019-12-31 | $301 |
| 2019-09-30 | $293 |
| 2019-06-30 | $289 |
| 2019-03-31 | $272 |
| 2018-12-31 | $257 |
| 2018-09-30 | $242 |
| 2018-06-30 | $244 |
| 2018-03-31 | $231 |
| 2017-12-31 | $236 |
| 2017-09-30 | $228 |
| 2017-06-30 | $230 |
| 2017-03-31 | $229 |
| 2016-12-31 | $225 |
| 2016-09-30 | $225 |
| 2016-06-30 | $219 |
| 2016-03-31 | $216 |
| 2015-12-31 | $216 |
| 2015-09-30 | $208 |
| 2015-06-30 | $204 |
| 2015-03-31 | $181 |
| 2014-12-31 | $186 |
| 2014-09-30 | $184 |
| 2014-06-30 | $179 |
| 2014-03-31 | $169 |
| 2013-12-31 | $178 |
| 2013-09-30 | $175 |
| 2013-06-30 | $177 |
| 2013-03-31 | $173 |
| 2012-12-31 | $159 |
| 2012-09-30 | $160 |
| 2012-06-30 | $165 |
| 2012-03-31 | $162 |
| 2011-12-31 | $150 |
| 2011-09-30 | $143 |
| 2011-06-30 | $148 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.365B | $1.830B |
| RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Quest Diagnostics (DGX) | United States | $23.013B | 21.00 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| Encompass Health (EHC) | United States | $11.082B | 20.17 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| LifeStance Health (LFST) | United States | $2.735B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| U.S Physical Therapy (USPH) | United States | $1.322B | 33.44 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Astrana Health (ASTH) | United States | $1.057B | 98.84 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |